Analysis on Survival and Prognostic Factors in Patients with Resectable Pancreatic Adenocarcinoma

被引:8
|
作者
Lin, Rong [1 ]
Han, Chao-qun [1 ]
Wang, Wei-jun [1 ]
Liu, Jun [1 ]
Qian, Wei [1 ]
Ding, Zhen [1 ]
Hou, Xiao-hua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; survival; prognosis; lymph node ratio; LONG-TERM SURVIVAL; LYMPH-NODE RATIO; NEOADJUVANT THERAPY; RISK-FACTORS; CANCER; RESECTION; OBESITY; IMPACT; LYMPHADENECTOMY; GEMCITABINE;
D O I
10.1007/s11596-017-1780-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survival after pancreatic cancer surgery is extremely unfavorable even after curative resection. Prognostic factors have been explored but remain largely undefined. The present study was to identify the role of clinical and laboratory variables in the prognostic significance of resectable pancreatic adenocarcinoma. A total of 96 patients who underwent curative resection for pancreatic cancer were included. Survival was evaluated based on complete follow-up visits and was associated with potential prognostic factors using the Kaplan-Meier method and Cox proportional hazard model survival analyses. The results showed that prognostic variables significantly reduced survival, including old age, poorly differentiated tumors, elevated tumor markers and positive lymph node metastasis (LNM). Age of older than 60 years (HR=1.83, P=0.04), LNM (HR=2.22, P=0.01), lymph node ratio (0<LNR <= 0.2, HR=1.38, P=0.042; LNR>0.2, HR=1.92, P=0.017), initial CA199 (HR=4.80, P=0.004), and CEA level (HR=2.59, P=0.019) were identified as independent prognostic factors by multivariate analysis. It was concluded that LNR may be potent predictor of survival and suggests that surgeons and the pathologists should thoroughly assess lymph nodes prior to surgery.
引用
收藏
页码:612 / 620
页数:9
相关论文
共 50 条
  • [1] Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma
    Rong Lin
    Chao-qun Han
    Wei-jun Wang
    Jun Liu
    Wei Qian
    Zhen Ding
    Xiao-hua Hou
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2017, 37 : 612 - 620
  • [2] Analysis on Survival and Prognostic Factors in Patients with Resectable Pancreatic Adenocarcinoma
    蔺蓉
    韩超群
    王玮珺
    刘俊
    钱伟
    丁震
    侯晓华
    Current Medical Science, 2017, (04) : 612 - 620
  • [3] Prognostic factors for resectable pancreatic adenocarcinoma
    Neuzillet, C.
    Sauvanet, A.
    Hammel, P.
    JOURNAL OF VISCERAL SURGERY, 2011, 148 (04) : E232 - E243
  • [4] Prognostic factors for survival in patients with resectable advanced gastric adenocarcinoma
    Medrano-Guzman, Rafael
    Valencia-Mercado, Daniel
    Luna-Castillo, Marisol
    Enrique Garcia-Rios, Luis
    Gonzalez-Rodriguez, Domingo
    CIRUGIA Y CIRUJANOS, 2016, 84 (06): : 469 - 476
  • [5] Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma
    Izumo, Wataru
    Higuchi, Ryota
    Furukawa, Toru
    Yazawa, Takehisa
    Uemura, Shuichirou
    Shiihara, Masahiro
    Yamamoto, Masakazu
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 780 - 786
  • [6] Prognostic factors related with survival in patients with pancreatic adenocarcinoma
    Ahmet Bilici
    World Journal of Gastroenterology, 2014, (31) : 10802 - 10812
  • [7] Prognostic factors related with survival in patients with pancreatic adenocarcinoma
    Bilici, Ahmet
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10802 - 10812
  • [8] The Glasgow Prognostic Score as a Predictor of Survival in Patients with Potentially Resectable Pancreatic Adenocarcinoma
    La Torre, Marco
    Nigri, Giuseppe
    Cavallini, Marco
    Mercantini, Paolo
    Ziparo, Vincenzo
    Ramacciato, Giovanni
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 2917 - 2923
  • [9] The Glasgow Prognostic Score as a Predictor of Survival in Patients with Potentially Resectable Pancreatic Adenocarcinoma
    Marco La Torre
    Giuseppe Nigri
    Marco Cavallini
    Paolo Mercantini
    Vincenzo Ziparo
    Giovanni Ramacciato
    Annals of Surgical Oncology, 2012, 19 : 2917 - 2923
  • [10] The Poor Prognostic Factors and the Risk Classification in Patients With Resectable Pancreatic Ductal Adenocarcinoma
    Yamaki, S.
    Satoi, S.
    Yamamoto, T.
    Kosaka, H.
    Hirooka, S.
    Kotsuka, M.
    Sakaguchi, T.
    Hashimoto, Y.
    Matsui, Y.
    Sekimoto, M.
    PANCREAS, 2019, 48 (10) : 1552 - 1552